Clostridium perfringens is a Gram-positive spore-forming bacterium that causes food poisoning. The neuraminidase (NA) protein of C. perfringens plays a pivotal role in bacterial proliferation and is considered a novel antibacterial drug target. Based on screens for novel NA inhibitors, a 95% EtOH extract of Corydalis turtschaninovii rhizome showed NA inhibitory activity (68% at 30 lg/ml), which resulted in the isolation of 10 isoquinoline alkaloids; namely, palmatine (1), berberine (2), coptisine (3), pseudodehydrocorydaline (4), jatrorrhizine (5), dehydrocorybulbine (6), pseudocoptisine (7), glaucine (8), corydaline (9) and tetrahydrocoptisine (10). Interestingly, seven quaternary isoquinoline alkaloids 1-7 (IC 50 = 12.8 ± 1.5 to 65.2 ± 4.5 lM) showed stronger NA inhibitory activity than the tertiary alkaloids 8-10. In addition, highly active compounds 1 and 2 showed reversible non-competitive behavior based on a kinetic study. Molecular docking simulations using the Autodock 4.2 software increased our understanding of receptorligand binding of these compounds. In addition, we demonstrated that compounds 1 and 2 suppressed bacterial growth.
Introduction
Clostridium perfringens is a Gram-positive spore-forming bacterium found in the human gastrointestinal tract, marine sediment, insects and soil. [1] [2] [3] This pathogen causes gas gangrene and food poisoning in humans, as well as enterotoxemia and enteritis in livestock. 4, 5 Food poisoning by C. perfringens in the USA and UK is the second most common foodborne disease. In the USA, 1 million cases of C. perfringens occur every year. 6 C. perfringens secretes over 15 toxins and enzymes, including the virulence factors encoded by the nanH, I and J genes, which can damage host tissue. 7, 8 Neuraminidase (EC. 3. 2. 1. 18, NA) from bacteria, named exo-asilidase, hydrolyzes a-glycosidic linkages of terminal sialic acid residues in oligosaccharides, glycoproteins and glycolipids on host cells. 9, 10 In fact, sialic acid, the N-or O-substituted derivatives of neuraminic acid from monosaccharides with a nine-carbon backbone, plays an important role in several cell-cell interactions and cell-molecule recognition processes and is a good source of nutrients for bacteria. 11, 12 Bacteria can obtain sialic acid via two routes: de novo synthesis or scavenging from the host. [12] [13] [14] Neuraminidase secreted from bacteria catalyzes the hydrolysis of the terminal sialic acids of sialoglycoconjugates in diverse organisms, and free sialic acid is directly transported into the bacterial membrane. 14 Sialic acid is then used as an energy and carbon source for bacterial growth. 12, 14 Moreover, neuraminidase plays a key role in the initial stages of bacterial infection, contributing to biofilm formation on glycoprotein-coated surfaces. 15, 16 Recent studies have highlighted neuraminidase as a novel target for development of therapeutic agents to treat bacterial infections. Therefore, we aimed to develop inhibitors of bacterial NA. Screening results of crude extracts from Corydalis turtschaninovii rhizomes demonstrated that the 95% EtOH extract at a concentration of 30 lg/ml had a 68% inhibitory effect on NA. Moreover, the inhibitory effects of berberine on viral NA, a quaternary isoquinoline alkaloid, found in this plant, have been reported. 17 Accordingly, seven quaternary and three tertiary isoquinoline alkaloids from the C. turtschaninovii rhizome were assessed for their activity against NA in vitro. The strong inhibitors (1, and 2) were non-competitive based on kinetic studies, and an allosteric site may have been associated with the molecule-inhibitor interaction based on docking simulations. Polyphenols, including flavanones, isoflavones and pterocarpans are known to have inhibitory activity against NA, but the activities of alkaloids and their derivatives from natural sources remain unknown. [18] [19] [20] 
Results and discussion

Isolation and structural elucidation
Ethanol extract from C. turtschaninovii rhizome showed 68% inhibitory activity against NA at 30 lg/ml. The ethanol extract was subjected to column chromatography on a silica gel and C-18 column to yield compounds 1-10. The chemical structures of isolated compounds 1-10 were identified by comparing their spectroscopic data (HPLC, ESI and HR-MS and 1D, 2D-NMR) with those published previously. The compounds were identified as palmatine (1), 22,23 berberine (2), 22 coptisine (3), 24 pseudodehydrocorydaline (4), 22,25 jatrorrhizine (5), 22 dehydrocorybulbine (6), 26 pseudocoptisine (7), 27 glaucine (8), 28 corydaline (9), 27 and tetrahydrocoptisine (10) 29 (Fig. 1 ).
Enzyme inhibition activity
To evaluate antibacterial activities, the inhibition by the isolated compounds of NA-catalyzed 4-methylumbelliferone formation from 4-methylumbelliferyl-a-D-N-acetyl neuraminic acid sodium salt hydrate was evaluated using fluorometeric determination with a SpectraMax M5 Multimode Reader (Molecular Devices, USA) in triplicate. Curcumin was used as a positive control. The results showed that palmatine (1) and berberine (2) showed strong inhibitory activity on NA with IC 50 values of 12.8 ± 1.5 and 13.5 ± 2.3 lM, respectively. Coptisine (3), pseudodehydrocorydaline (4), jatrorrhizine (5) dehydrocorybulbine (6), pseudocoptisine (7) , and glaucine (8) showed moderate inhibitory activity (IC 50 25.1 ± 0.8 to 96.9 ± 3.2 lM). In contrast, corydaline (9) and tetrahydrocoptisine (10) showed little effect, with 12.7 and 4.6%, respectively, inhibition of NA activity at 100 lM. Subsequently, compounds 1-10 suppressed viral NA activity. Viral NAs from rvH1N1 and H5N1 were inhibited by quaternary isoquinoline alkaloids 1-7 (Table 1) . Among them, compound 3 showed IC 50 values of 25.3 ± 0.4 and 26.4 ± 1.1 lM against rvH1N1 and H5N1, respectively, which were greater than the corresponding values of compound 2 (38.5 ± 1.2 and 32.2 ± 0.5 lM). Compound 2 was previously considered a viral NA inhibitor (Fig. 2 ). 17 
Enzyme kinetic study
The binding mechanisms of inhibitors were examined using enzyme-inhibitor kinetic studies. The data for highly active compounds 1 and 2 are shown in Figure 3 . Plots of NA activity versus concentration of the two inhibitors yielded a group of straight lines passing through the origin, indicating that they were reversible inhibitors ( Fig. 3A and D) . Double reciprocal Michaelis-Menten and Dixon plots were generated by measurement of enzyme activity with various substrates at different concentrations. The results are presented in Figure 3 . These compounds showed non-competitive behavior as indicated by their different V max values and equal K m values in the Michaelis-Menten plot ( Fig. 3B and E). Additionally, the Dixon plots confirmed that the K i of compounds 1 and 2 were 16.9 ± 1.5 and 11.9 ± 1.9 lM, respectively, ( Fig. 3C and F).
Structure activity relationships (SARs)
Based on their inhibition of bacterial NA, this study explored the structure-activity relationships of isoquinoline alkaloids (1-10). Quaternary isoquinoline alkaloids (1-7) showed stronger inhibition of NA than tertiary isoquinoline alkaloids (8-10). Among compounds 1-7, structures with a hydroxyl group at C-3 showed low activity against NA. For example, compounds 5 (IC 50 : 37.7 ± 1.8 lM) and 6 (IC 50 : 41.3 ± 3.5 lM), which contain a free hydroxyl group at C-3, showed an NA inhibitory effect 3-to 3.5-fold lower than that of compound 1 (IC 50 : 12.8 ± 1.5 lM). Finally, compounds substituted with free methoxyl groups instead of 1, 3-dioxolane at C-2, 3 and C-9, 10 increased NA inhibition based on comparisons with compounds 1 (IC 50 , 12.8 ± 1.5 lM), 2 (IC 50 , 13.5 ± 2.3 lM) and 3 (IC 50 , 25.5 ± 0.8 lM).
Molecular simulation
Because compounds 1 and 2 exhibited strong inhibitory activities in vitro, we examined the binding mode of these compounds with their receptor (code: 2BF6 from protein data bank) using the docking software package AUTODOCK 4.2. Based on kinetic studies, rigid receptor-flexible ligand docking was performed to set up grids containing the full receptor for blind testing using the AutoDockTools. This revealed the low docking energy and allosteric binding site opportunities of binding forms between flexible ligands and activity sites (Fig. 4 ). Molecular simulation results showed a trend similar to the enzyme assays with binding energies for palmatine (À8.66 kcal/mol) and berberine (À8.27 kcal/mol). Compound 1 was closely associated with 15 amino acids in the receptor. Among them, GLU385, ASN386, ASN417 and ASN448 were individually linked by hydrogen bonding with 2.4, 2.3, 2.0, and 1.9 Å distances to palmatine (1). Compound 2 was proximal to 12 amino acids. Berberine (2) formed hydrogen bonds with ASN417 (2.12 Å) Table 2 . Interestingly, ring A of the two ligands was close to TRY320 and HIS346 in the binding site ( Fig. 4B and Fig. 45 in supporting data). Palmatine (1) interacted only via p-p stacking with HIS346, and berberine (2) exhibited p-p stacking with TRY320 and HIS346. Two ligands superimposed into the allosteric binding site are shown in Figure 4 .
Antibacterial assay
To confirm the antibacterial activity of compounds 1 and 2, their effects on C. perfringens growth in the presence and absence of the inhibitor were examined and expressed as MIC values ( 
Conclusion
We identified a novel inhibitor of NA from C. perfringens, a causative agent of food poisoning. Activity-guided fractionation of 95% ethanol extract from C. turtschaninovii rhizome led to the isolation of isoquinoline alkaloids 1-10. Among them, palmatine (1) and berberine (2) , which contain the quaternary isoquinoline alkaloid backbone, exhibited NA inhibitory activity. Previous reports have examined inhibitors of two exo-sialidases for bacterial and viral NAs because they have similar active sites and overall mechanism of action. 30, 31 We also found similar results for viral and bacterial NA. In particular, coptisine (3) showed stronger inhibitory activity than berberine (2), which has been reported to be a viral NA inhibitor. 17 Isoquinoline alkaloids inhibited bacterial NA and suppressed viral activity. Based on the kinetic study and molecular simulations, the quaternary isoquinoline alkaloids 1 and 2 showed reversible non-competitive behavior in the ligand-receptor interaction for the inhibition of NA. In addition, the location for binding was predicted to be an allosteric site based on the optimal position of the ligands. Based on this information, the negatively charged amino acids ASN 417 and positively charged HIS 346 in the binding site, which are common residues of amino acid for hydrogen bonds and p-p stacking interactions with two ligands, provided little information for the development of new non-competitive NA inhibitors. Finally, palmatine (1) and berberine (2) suppressed bacterial growth and may thus represent potential novel antibacterial agents.
Materials and methods
General experimental procedures
NMR spectra were obtained on a JNM-ECA 400 and 600 MHz (JEOL, Tokyo, Japan) spectrometer using DMSO-d 6 and methanold 4 as solvents. HPLC analysis using the Chemstation software was performed using an Agilent 1200 series equipped with a binary pump and visible wavelength detector (VWD). The analytical column was a YMC-Pack amino column (250 Â 4.6-mm i.d.). Molecular weight was determined using ESI MS (Esquire 6000, Bruker). Melting points were measured using an Electrothermal IA-92 00 instrument and chromatographic separations were performed by thin-layer chromatography (TLC) with commercially available glass plates pre-coated with normal and reverse-phase silica gel 
Plant material
C. turtschaninovii rhizomes were purchased from an herbal drug-store in Jeongeup city, Jeollabuk-do, Republic of Korea, in August 2012, and were identified by one of the authors (Prof. Young Ho Kim). A voucher specimen (CNU-13129) was deposited at the Herbarium of College of Pharmacy, Chungnam National University, Republic of Korea.
Isolation and Identification
C. turtschaninovii rhizomes (3.6 kg) were extracted with 95% EtOH (18 L) at room temperature over 7 days. After removing solvent under reduced pressure, a dark brownish residue (120 g) was obtained. The crude extract (120 g) was separated using silica-gel column chromatography with a gradient solvent system of CHCl 3 /MeOH (20:1 ? 0.5:1) to yield seven fractions (1) (2) (3) (4) (5) (6) (7) . Fraction 1 (14 g) was subjected to MPLC using gradient elution with CHCl 3 /MeOH (10:1 ? 2:1) to yield four sub-fractions (1.1-1.4). Compounds 10 (20 mg) and 7 (30 mg) were isolated from fraction 1.3 (4 g) on a C-18 column eluted with H 2 O/MeOH (10:1 ? 0.1:1). Sub-Fraction 1.4 was separated using C-18 column chromatography with gradient elution of H 2 O/MeOH (10:1 ? 2.5:1) to afford compound 1 (45 mg). Fraction 3 (24 g) was subjected to silica gel column chromatography using gradient CHCl 3 /MeOH (20:1 ? 0.25:1) to yield seven sub-fractions (3.1-3.7). Sub-fraction 3.2 (2 g) was subjected to MPLC using gradient solvent (CHCl 3 /MeOH, 20:1 ? 0.1:1) to yield compounds 5 (13 mg) and 8 (32 mg). Subfraction 3.4 (12 g) was loaded on the MPLC system and eluted with CHCl 3 /MeOH (10:1 ? 0.5:1) to afford compounds 2 (7 mg), 4 (300 mg) and 9 (18 mg). Sub-fraction 3.6 (5 g) was chromatographed using a Sephadex LH-20 column and eluted with 100% MeOH to afford seven smaller fractions (3.6.1-3.6.7). Sub-fraction 3.6.5 (540 mg) was subjected to MPLC using gradient solvent (CHCl 3 /MeOH, 20:1 ? 0.25:1) to yield compounds 3 (5 mg) and 6 (8 mg).
Enzyme inhibition assay
All enzyme assays were performed as described previously using bacterial NA with minor modifications. 18 Briefly, each 50 ll of NA (0.1 mg/ml) in buffer and 20 ll of the respective ligands diluted from 100 lM to 6.25 lM dissolved in MeOH were mixed in 96-well plates containing 80 ll of 50 mM sodium acetate buffer (pH 5.0). Finally, 50 ll of 0.5 mM 4-methylumbelliferyl-a-D-Nacetylneuraminic acid sodium salt hydrate were added as a substrate. After starting the enzyme reaction at room temperature, 4-methylumbelliferone quantification intensity (RFU) was measured using fluorometric determination (excitation wavelength, 365 nm; emission wavelength, 450 nm) with a SpectraMax M 2e Multimode Reader (Molecular Devices, USA) for 10 min. The inhibition ratio was calculated using the equation:
Inhibitory ð%Þ ¼ 100 À ½Dligand absorbanceÞ=ðDcontrol absorbanceÞ Â 100
Curcumin was used as the positive control.
Molecular simulation
The 3D structure of the ligand was modeled using the GlycoBio-Chem PRODRG2 server and the flexible bonds of ligands were assigned with AutoDockTools. The structure of NA (PDB ID: 2BF6) was obtained from the protein data bank, after which the water, glycerol and O-sialic acid were removed from receptor complexes using Chimera. All hydrogen atoms and gasteiger charges in the receptor were added using AutoDockTools. Simulation studies were performed using the AUTODOCK 4.2 software according to the instructions provided on the Autodock Homepage (http://autodock.scripps.edu/). Briefly, to perform blind docking in AUTODOCK 4.2, the grid dimensions were establishing using grid center (X: 84.8, Y: À0.5, Z: 11.4), number of points (X: 150, Y: 200, Z: 150) and spacing (0.375 Å). Both ligand and receptor docking were performed using the Lamarckian Genetic Algorithm (Runs 50) after the default parameter settings generated by the AutoDockTools were used for docking, except that the maximum number of evals was set as long. The molecular simulation results are shown in Figure 4 and were prepared using Chimera.
Antibacterial activity assay
To confirm the inhibitory activity of compounds 1 and 2 on viable bacteria, C. perfringens was cultured in tryptic soy broth (TSB) at 37°C with continuous shaking in an anaerobic environment for 24 h. Growth was monitored by measuring turbidity at 600 nm.
Bacteria diluted 1:100 in TBS (198 ll) were cultured in the presence and absence of compounds 1 and 2 dissolved in DMSO (3.1-100 lM). A total of 40 ll of 1% p-INT was added to the each well of the plates, followed by incubation for 30 min. Absorbance was determined at 600 nm. 21 
Statistical analysis
All activity tests in the presence of inhibitors were performed in triplicate and results are presented as the means ± standard error of the mean (SEM). The results were subjected to analysis using Sigma Plot (SPP Inc., Chicago, IL, USA).
